Oscar Health Stock Target Lifted to $45-$49 on ACA Gains
Oscar Health (OSCR) targets a $45 to $49 fair value range as membership expands 60% within the ACA market. Investors are tracking scalable growth, an 81.5% medical loss ratio, and long-term 2029 guidance following recent equity analysis.
If Oscar Health sustains its membership growth and margin trajectory, watch for continued upside momentum toward the $45–$49 fair value range identified by analysts. Traders should monitor upcoming quarterly reports and Lucie marketplace segment disclosures as critical near-term execution catalysts.